Rheumatology Network

Latest from the World Congress on Osteoarthritis

New reports about the biology of OA appear so fast it's hard to keep up, said a speaker at the Osteoarthritis Research Society International meeting, held April 30-May 3 in Seattle.

Read on-the-spot coverage about the best biomarkers of progression, the latest on hyaluronic acid injections, how to exercise a "bad knee," and more ....

Recent Content

A small prospective study finds that patients with psoriatic arthritis eventually revert to disease if TNF-alpha drugs are discontinued, sometimes as much as 6 months later.

The approved psoriatic arthritis drug apremilast reduced the number and painfulness of oral ulcers in a Phase 2 trial of Behçet syndrome.

(OARSI2015) First results are now in for a large collaborative project whose goal is to rationalize OA research by finding the best imaging and biochemical measures of progression.

(OARSI2015) Musculoskeletal signs predict which patients will do poorly after joint replacement surgery, but the Medicare agency does not include these in rating hospitals. The information could also be useful for surgeons and patients, says this investigator.

(OARSI2015) A randomized trial has shown that 6 months of treatment with hydroxychloroquine does not provide better relief for hand osteoarthritis than placebo.

New ACR/EULAR criteria for systemic sclerosis capture patients who present with Raynaud syndrome. Watch for those who have sclerodacytly or telangectasia.

(OARSI2015) What advice about exercise is prudent for your patients with knee osteoarthritis? Speakers in Seattle offered a few simple suggestions, based on the latest research.

By clicking Accept, you agree to become a member of the UBM Medica Community.